Pramipexole - NDC Database (Page 15)
70771-1331 Apr 24, 2018
Pramipexole Dihydrochloride 2.25 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
Pramipexole Dihydrochloride 2.25 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
70771-1332 Apr 24, 2018
Pramipexole Dihydrochloride 3 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
Pramipexole Dihydrochloride 3 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
70771-1333 Apr 24, 2018
Pramipexole Dihydrochloride 3.75 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
Pramipexole Dihydrochloride 3.75 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
70771-1334 Apr 24, 2018
Pramipexole Dihydrochloride 4.5 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
Pramipexole Dihydrochloride 4.5 mg Oral Tablet, Extended Release by Cadila Healthcare Limited
71034-002 Jun 11, 2021
Pramipexole Dihydrochloride Extended-release .375 mg Oral Tablet, Extended Release by Xiamen Lp Pharmaceutical Co., Ltd.
Pramipexole Dihydrochloride Extended-release .375 mg Oral Tablet, Extended Release by Xiamen Lp Pharmaceutical Co., Ltd.
71034-003 Jun 11, 2021
Pramipexole Dihydrochloride Extended-release .75 mg Oral Tablet, Extended Release by Xiamen Lp Pharmaceutical Co., Ltd.
Pramipexole Dihydrochloride Extended-release .75 mg Oral Tablet, Extended Release by Xiamen Lp Pharmaceutical Co., Ltd.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.